Literature DB >> 31704216

Successful treatment of septic shock due to NDM-1-producing Klebsiella pneumoniae using ceftazidime/avibactam combined with aztreonam in solid organ transplant recipients: report of two cases.

Laura Benchetrit1, Vincent Mathy2, Laurence Armand-Lefevre3, Lila Bouadma4, Jean-François Timsit5.   

Abstract

Entities:  

Year:  2019        PMID： 31704216     DOI： 10.1016/j.ijantimicag.2019.10.023

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN： 0924-8579            Impact factor:   5.283


× No keyword cloud information.
  9 in total

Review 1.  Update of clinical application in ceftazidime-avibactam for multidrug-resistant Gram-negative bacteria infections.

Authors:  Sisi Zhen; Hui Wang; Sizhou Feng
Journal:  Infection       Date:  2022-07-04       Impact factor: 3.553

2.  Successful treatment of Verona integron-encoded metallo-β-lactamase-producing Klebsiella pneumoniae infection using the combination of ceftazidime/avibactam and aztreonam.

Authors:  Ana Pelaez Bejarano; Raquel Sánchez-Del Moral; Olalla Montero-Pérez; Francisco Javier Martínez-Marcos
Journal:  Eur J Hosp Pharm       Date:  2021-10-29

3.  In-vitro susceptibility testing methods for the combination of ceftazidime-avibactam with aztreonam in metallobeta-lactamase producing organisms: Role of combination drugs in antibiotic resistance era.

Authors:  Priya Sreenivasan; Bhawna Sharma; Satinder Kaur; Sudesh Rana; Manisha Biswal; Pallab Ray; Archana Angrup
Journal:  J Antibiot (Tokyo)       Date:  2022-06-17       Impact factor: 3.424

Review 4.  β-Lactam Antibiotics and β-Lactamase Enzymes Inhibitors, Part 2: Our Limited Resources.

Authors:  Silvana Alfei; Anna Maria Schito
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-13

5.  Successful treatment of infective endocarditis due to pandrug-resistant Klebsiella pneumoniae with ceftazidime-avibactam and aztreonam.

Authors:  Majed F Alghoribi; Moayad Alqurashi; Liliane Okdah; Bassam Alalwan; Yahya S AlHebaishi; Abdulmajeed Almalki; Maha A Alzayer; Abdulrahman A Alswaji; Michel Doumith; Mazin Barry
Journal:  Sci Rep       Date:  2021-05-06       Impact factor: 4.379

Review 6.  Ceftazidime/Avibactam and Ceftolozane/Tazobactam for Multidrug-Resistant Gram Negatives in Patients with Hematological Malignancies: Current Experiences.

Authors:  Marianna Criscuolo; Enrico Maria Trecarichi
Journal:  Antibiotics (Basel)       Date:  2020-02-03

Review 7.  Therapeutic Options for Metallo-β-Lactamase-Producing Enterobacterales.

Authors:  Xing Tan; Hwan Seung Kim; Kimberly Baugh; Yanqin Huang; Neeraja Kadiyala; Marisol Wences; Nidhi Singh; Eric Wenzler; Zackery P Bulman
Journal:  Infect Drug Resist       Date:  2021-01-18       Impact factor: 4.003

Review 8.  New Carbapenemase Inhibitors: Clearing the Way for the β-Lactams.

Authors:  Juan C Vázquez-Ucha; Jorge Arca-Suárez; Germán Bou; Alejandro Beceiro
Journal:  Int J Mol Sci       Date:  2020-12-06       Impact factor: 5.923

Review 9.  Treatment of Severe Infections Due to Metallo-Betalactamases Enterobacterales in Critically Ill Patients.

Authors:  Jean-François Timsit; Paul-Henri Wicky; Etienne de Montmollin
Journal:  Antibiotics (Basel)       Date:  2022-01-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.